Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group study.
| Image |  |
|---|---|
| Description | scientific article published on 12 July 2011 |
| Author/s |
author: Kian Behbakht R Katherine Alpaugh |
| Publication date | July 12, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |